NO | Các sản phẩm | CAS Không | Chỉ báo chất lượng chính | |||
Sự tinh khiết | Tối đa tạp chất | Tổng dư lượng dung môi | Độ ẩm | |||
1 | Fmoc-β-Ala-Ala-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
2 | Fmoc-D-Ala-D-Ala-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
3 | Fmoc-β-Ala-D-Ala-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
4 | Fmoc-Arg (pbf) -Arg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
5 | Fmoc-β-Ala-Arg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
6 | Fmoc-D-Arg (pbf) -D-Arg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
7 | Fmoc-β-Ala-D-Arg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
8 | Fmoc-HomoArg (pbf) -HomoArg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
9 | Fmoc-β-Ala-HomoArg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
10 | Fmoc-Asn (Trt) -Asn (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
11 | Fmoc-β-Ala-Asn (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
12 | Fmoc-Asp (OtBu) -Asp (OtBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
13 | Fmoc-β-Ala-Asp (OtBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
14 | Fmoc-Cys (Trt) -Cys (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
15 | Fmoc-β-Ala-Cys (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
16 | Fmoc-Cys (Acm) -Cys (Acm) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
17 | Fmoc-β-Ala-Cys (Acm) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
18 | Fmoc-Gln (Trt) -Gln (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
19 | Fmoc-β-Ala-Gln (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
20 | Fmoc-Glu (OtBu) -Glu (OtBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
21 | Fmoc-β-Ala-Glu (OtBu) -OH.H2O | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
22 | Fmoc-β-Ala-Gly-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
23 | Fmoc-His (Trt) -His (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
24 | Fmoc-β-Ala-His (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
25 | Fmoc-Ile-Ile-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
26 | Fmoc-β-Ala-Ile-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
27 | Fmoc-Leu-Leu-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
28 | Fmoc-β-Ala-Leu-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
29 | Fmoc-D-Leu-D-Leu-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
30 | Fmoc-β-Ala-D-Leu-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
31 | Fmoc-Lys (Boc) -Lys (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
32 | Fmoc-β-Ala-Lys (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
33 | Fmoc-Lys (Alloc) -Lys (Alloc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
34 | Fmoc-β-Ala-Lys (Alloc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
35 | Fmoc-Met-Met-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
36 | Fmoc-β-Ala-Met-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
37 | Fmoc-Orn (Boc) -Orn (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
38 | Fmoc-β-Ala-Orn (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
39 | Fmoc-Phe-Phe-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
40 | Fmoc-β-Ala-Phe-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
41 | Fmoc-D-Phe-D-Phe-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
42 | Fmoc-β-Ala-D-Phe-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
43 | Fmoc-Pro-Pro-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
44 | Fmoc-β-Ala-Pro-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
45 | Fmoc-Ser (tBu) -Ser (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
46 | Fmoc-β-Ala-Ser (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
47 | Fmoc-Ser (Trt) -Ser (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
48 | Fmoc-β-Ala-Ser (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
49 | Fmoc-Thr (tBu) -Thr (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
50 | Fmoc-β-Ala-Thr (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
51 | Fmoc-Trp (Boc) -Trp (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
52 | Fmoc-β-Ala-Trp (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
53 | Fmoc-D-Trp (Boc) -D-Trp (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
54 | Fmoc-β-Ala-D-Trp (Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
55 | Fmoc-Tyr (tBu) -Tyr (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
56 | Fmoc-β-Ala-Tyr (tBu) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
57 | Fmoc-D-Tyr (Et) -D-Tyr (Et) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
58 | Fmoc-β-Ala-D-Tyr (Et) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
59 | Fmoc-Tyr (Tôi) -Tyr (Tôi) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
60 | Fmoc-β-Ala-Tyr (Tôi) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
61 | Fmoc-Val-Val-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
62 | Fmoc-β-Ala-Val-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
63 | Fmoc-D-Cit-D-Cit-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
64 | Fmoc-β-Ala-D-Cit-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
65 | Fmoc-β-Ala-Dab-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
66 | Fmoc- (3- (2-naphtyl) -D-Ala) 2-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
67 | Fmoc-β-Ala-3- (2-naphtyl) -D-Ala-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
68 | Fmoc- (3- (3-pyridinyl) -D-Ala) 2-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
69 | Fmoc-β-Ala-3- (3-pyridinyl) -D-Ala-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
70 | Fmoc- (4-clo-D-Phe) 2-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
71 | Fmoc-β-Ala-4-clo-D-Phe-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
72 | Fmoc- (D-4Aph (tBuCbm)) 2-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
73 | Fmoc-β-Ala-D-4Aph (tBuCbm) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
74 | Fmoc-Aph (L-Hor) -Aph (L-Hor) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
75 | Fmoc-β-Ala-Aph (L-Hor) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
76 | Fmoc-Lys (iPr, Boc) -Lys (iPr, Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
77 | Fmoc-β-Ala-Lys (iPr, Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
78 | Fmoc-β-Ala-AEEA-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
79 | Fmoc-Aib-Aib-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
80 | Fmoc-β-Ala-Aib-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
81 | Fmoc-Arg-OH | 91000-69-0 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
82 | H-Arg (pbf) -OH | 200115-86-2 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
83 | Fmoc-D-Arg-OH | 130752-32-8 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
84 | HD-Arg (pbf) -OH | 200116-81-0 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
85 | Fmoc-HomoArg-OH.HCl | 208174-14-5 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
86 | H-HomoArg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
87 | Fmoc-D-HomoArg-OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
88 | HD-HomoArg (pbf) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
89 | Fmoc-Asn-OH | 71989-16-7 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
90 | H-Asn (Trt) -OH | 132388-58-0 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
91 | Fmoc-Asp-OH | 119062-05-4 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
92 | H-Asp (OtBu) -OH | 3057-74-7 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
93 | Fmoc-Cys-OH | 135248-89-4 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
94 | H-Cys (Trt) -OH | 2799/7/7 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
95 | H-Cys (Acm) -OH.HCl | 28798-28-9 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
96 | Fmoc-Gln-OH | 71989-20-3 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
97 | H-Gln (Trt) -OH | 102747-84-2 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
98 | Fmoc-Glu-OH | 121343-82-6 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
99 | H-Glu (OtBu) -OH.H2O | 2419-56-9 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
100 | Fmoc-His-OH | 116611-64-4 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
101 | H-Của anh ấy (Trt) -OH | 35146-32-8 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
102 | Boc-His-OH | 17791-52-5 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
103 | Fmoc-Lys-OH | 105047-45-8 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
104 | H-Lys (Boc) -OH | 2418-95-3 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
105 | H-Lys (Alloc) -OH | 6298/3/9 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
106 | Fmoc-Orn-OH.HCl | 201046-57-3 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
107 | H-Orn (Boc) -OH | 13650-49-2 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
108 | Fmoc-Ser-OH | 73724-45-5 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
109 | H-Ser (tBu) -OH | 18822-58-7 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
110 | H-Ser (Trt) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
111 | Fmoc-Thr-OH.H2O | 73731-37-0 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
112 | H-Thr (tBu) -OH | 4378-13-6 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
113 | Fmoc-Trp-OH | 35737-15-6 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
114 | H-Trp (Boc) -OH | 146645-63-8 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
115 | Fmoc-D-Trp-OH | 86123-11-7 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
116 | HD-Trp (Boc) -OH | 201290-11-1 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
117 | Fmoc-Tyr-OH | 92954-90-0 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
118 | H-Tyr (tBu) -OH | 18822-59-8 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
119 | Fmoc-D-Tyr-OH | 112883-29-1 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
120 | HD-Tyr (Et) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
121 | H-Tyr (Tôi) -OH.HCl | 67423-44-3 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
122 | Fmoc-D-4Aph (Cbm) -OH | 324017-22-3 | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
123 | HD-4Aph (tBuCbm) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
124 | Fmoc-Lys (iPr) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
125 | H-Lys (iPr, Boc) -OH | NA | ≥98,0% | ≤1,0% | ≤8,0% | ≤2.0% |
Đền bù
Gentolex cung cấp những sản phẩm chất lượng tuyệt vời, nếu khách hàng nâng cao chất lượng sản phẩm trong khung thời gian yêu cầu với đầy đủ bằng chứng, chúng tôi sẽ đưa ra những phân tích, đánh giá cần thiết để tiến hành thủ tục đền bù.
Sản lượng
Năng lực của các sản phẩm dược phẩm đạt cấp tấn, công suất của các sản phẩm hóa chất đạt cấp độ 100 tấn +, khả năng được trang bị tốt để phục vụ khách hàng trên toàn thế giới.
Nghiên cứu và phát triển
Hàng năm, nhóm R&D đều có kế hoạch phát triển các sản phẩm mới khác nhau, khi đạt được mục tiêu, mọi thành viên trong nhóm sẽ phải thực hiện trách nhiệm KPI và có chính sách khuyến khích.